Umbilical Artery Leucine‐Rich α‐2 Glycoprotein as a Predictor of Bronchopulmonary Dysplasia in Preterm Infants

Documenti analoghi

• Comment on “Umbilical Artery Leucine‐Rich α‐2 Glycoprotein as a Predictor of Bronchopulmonary Dysplasia in Preterm Infants”
  di: Yi‐Li Hung, et al.
  Pubblicazione: (2026)
• Predictive score using umbilical vein leucine‐rich α‐2 glycoprotein as a useful biomarker for diagnosing histological chorioamnionitis in preterm infants
  di: Genichiro Sotodate, et al.
  Pubblicazione: (2025)
• Azithromycin for Preventing Bronchopulmonary Dysplasia in Extremely Preterm Infants: A Cohort Study
  di: Yali Zeng, et al.
  Pubblicazione: (2024)
• Respiratory Outcomes Following Late Postnatal Dexamethasone Administration in Preterm Infants With Bronchopulmonary Dysplasia
  di: Melissa House, et al.
  Pubblicazione: (2025)
• Dynamic Risk‐Stratification Models for Bronchopulmonary Dysplasia in Extremely Preterm Very Low Birth Weight Infants
  di: Ting Zhao, et al.
  Pubblicazione: (2025)